HTA114 Review of Health Technology Assessment (HTA) and Recommendations for the Introduction of Higher-Valency Pneumococcal Conjugated Vaccine (PCV) in 4 European Countries, The United-Kingdom (UK), and The United-States (US)
Abstract
Authors
R Noharet-Koenig K Lasota P Faivre E Langevin